Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8133853 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Sepsis
Interventions: Drug: IVIG;   Drug: Placebo

Indicates status has not been verified in more than two years